EP3302524
USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF GLAUCOMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.5.2016EP published:
23.9.2020EP application number:
16729691.2
EPO information:
European Patent Register
Max expiry date:
26.5.2036
Title:
USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF GLAUCOMA
Timeline
Today
27.5.2016EP application
23.9.2020EP Publication
Owner
Name:
Neurotech USA, Inc.Address:
900 Highland Corporate Drive Building No. 1 Suite No. 101, Cumberland, RI 02864, US
Inventor
Name:
GOLDBERG, Jeffrey, LouisAddress:
San Diego, CA 92130, US
Name:
MCGOVERN, CahilAddress:
North Kingstown, RI 02852, US
Name:
TAO, WengAddress:
Lincoln, RI 02865-1327, US
Name:
KAUPER, KonradAddress:
Sutton, MA 01590, US
Priority
Number:
201562167213 PDate:
27.5.2015Country:
US
Classification
Categories:
A61K 38/18, A61K 38/19, A61K 38/20, A61K 38/21, A61F 2/16, A61K 9/00, A61K 35/30, A61P 27/02, A61P 27/06